Bicycle Therapeutics plc
BCYC News Today: Stay Updated with the Latest Bicycle Therapeutics plc News in Real Time
Find BCYC news now at Meyka AI. Stay informed with the latest Bicycle Therapeutics plc stocks updates, including price news, market analysis, and expert insights.
WPP (NYSE) Neutral Rating Maintained by Citi – May 2026
Citigroup maintains Neutral rating on WPP, raises price target to 285 GBp from 275 GBp. Stock trades at $18.09 with B grade.
CHM.AX stock surges 7650% on massive 153,880 share volume spike
CHM.AX stock explodes 7650% to A$0.155 on record volume. Chimeric Therapeutics shows extreme volatility amid cell therapy development.
2888.HK Standard Chartered Earnings Preview April 30
Standard Chartered 2888.HK earnings preview: analysts expect $4.95 EPS and $44.25B revenue on April 30, 2026.
AAM.SW Stock Drops 6% in Pre-Market Trading on May 1
Anglo American plc (AAM.SW) falls 6.03% to CHF37.4 in pre-market trading. Mining stock faces strong sell rating and negative earnings outlook.
4883.T Stock Surges 21% in Pre-Market Trading on May 1
Modalis Therapeutics (4883.T) jumps 21% in pre-market session on JPX. Stock price reaches ¥80 with volume spike to 35.4M shares.
LYG Lloyds Banking Group Earnings Beat: EPS Crushes Estimates
Lloyds Banking Group beat EPS estimates by 18% with $0.13 actual vs $0.11 expected, though revenue missed slightly at $6.46B.
GSK plc (GSK) Earnings Beat: Q1 2026 Results Exceed Expectations
GSK plc beat Q1 2026 earnings with $1.24 EPS vs $1.16 estimate and $10.30B revenue vs $10.23B forecast.
LOBE.CN stock surges 42% on April 30, 2026 as psychedelic biotech gains momentum
LOBE.CN stock jumps 42.1% to C$0.135 on April 30, 2026. Lobe Sciences Ltd. advances psilocybin therapeutics for PTSD and brain injuries.
AZN AstraZeneca Earnings Beat: Q1 2026 Results Exceed Expectations
AstraZeneca PLC (AZN) beat Q1 2026 earnings estimates with $2.58 EPS and $15.29B revenue, up 2.79% and 2.05% respectively.